A delivery of 600,000 doses of the AstraZeneca vaccine arrived in Accra on Wednesday. The first recipients are due to be healthcare workers. The Covax scheme aims to reduce the divide between rich countries and poorer nations unable to buy doses. The programme is planning to deliver about two billion vaccine doses globally by the end of the year. Ghana, which has a population of over 30m, was chosen as the first recipient of the free vaccines after promising quick distribution and meeting the criteria set by Covax. Further deliveries are expected to neighbouring Ivory Coast later this week, the Covax alliance says. Vaccinations are expected to start in Ghana next week, and, as well as health workers, those over 60, people with underlying health conditions, and senior officials are due to be prioritised. The vaccines delivered to Accra were produced by the Serum Institute of India and developed by AstraZeneca and Oxford University. The vaccine has been approved by the World Health Organization (WHO) and its roll-out in Ghana is not part of a trial. As well as procuring and delivering the vaccines, Covax partners are supporting local authorities in areas such as training people to administer the jabs and helping provide an adequate cold-chain storage and delivery system.
SOURCE: WASHINGTON POST
Kagame Shakes Up his Cabinet
Trauma Experienced by Staff at Nairobi Facebook Hub recognised in Legal Ruling
Two Nigerian States have Reduced the Working Week to Three Days for State Employees
Dakar Moves to Quell the Diaspora
Kenya’s Plans to Remember Victims of a Cult
What’s the Background to Tanzania’s Capital City Relocation?
Nigerian Man Becomes Mayor of Colorado
Egypt Faces Mounting Challenges in Generating Funds for International Debt Obligations
Enhanced Protection Strategies Fuel the Resurgence of Carnivores in Zambia
Ugandan Students Explore the Future of Gardening
A Great Recognition for the Work of Female Peace Builders in Cameroon
Could An Online Gathering Solve South Africa’s Putin Problem?